These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 37446614)
1. Integration of Hybridization Strategies in Pyridine-Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic Insights. Godesi S; Nada H; Lee J; Kang JH; Kim SY; Choi Y; Lee K Molecules; 2023 Jun; 28(13):. PubMed ID: 37446614 [TBL] [Abstract][Full Text] [Related]
2. Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAF Ali EMH; Mersal KI; Ammar UM; Zaraei SO; Abdel-Maksoud MS; El-Gamal MI; Haque MM; Das T; Kim EE; Lee JS; Lee KH; Kim HK; Oh CH Eur J Pharm Sci; 2022 Apr; 171():106115. PubMed ID: 34995782 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2. Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological evaluation, and in silico studies of 2-aminobenzothiazole derivatives as potent PI3Kα inhibitors. Haider K; Ahmad K; Najmi AK; Das S; Joseph A; Shahar Yar M Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200146. PubMed ID: 35665957 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents. Hafez HN; El-Gazzar ABA Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines. Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents. Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686 [TBL] [Abstract][Full Text] [Related]
10. Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities. Shawky AM; Ibrahim NA; Abourehab MAS; Abdalla AN; Gouda AM J Enzyme Inhib Med Chem; 2021 Dec; 36(1):15-33. PubMed ID: 33103497 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer assessment on human breast, liver and colon carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives. Metwally NH; Deeb EA Bioorg Chem; 2018 Apr; 77():203-214. PubMed ID: 29367077 [TBL] [Abstract][Full Text] [Related]
13. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors. Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416 [TBL] [Abstract][Full Text] [Related]
14. Pyridine-Ureas as Potential Anticancer Agents: Synthesis and In Vitro Biological Evaluation. El-Naggar M; Almahli H; Ibrahim HS; Eldehna WM; Abdel-Aziz HA Molecules; 2018 Jun; 23(6):. PubMed ID: 29914120 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
16. Development of certain aminoquinazoline scaffolds as potential multitarget anticancer agents with apoptotic and anti-proliferative effects: Design, synthesis and biological evaluation. Amin NH; El-Saadi MT; Abdel-Fattah MM; Mohammed AA; Said EG Bioorg Chem; 2023 Jun; 135():106496. PubMed ID: 36989735 [TBL] [Abstract][Full Text] [Related]
17. Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study. Wang R; Zhao X; Yu S; Chen Y; Cui H; Wu T; Hao C; Zhao D; Cheng M Bioorg Chem; 2020 Sep; 102():104092. PubMed ID: 32707280 [TBL] [Abstract][Full Text] [Related]
18. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors. Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approach. Azimian F; Hamzeh-Mivehroud M; Shahbazi Mojarrad J; Hemmati S; Dastmalchi S Eur J Med Chem; 2020 Sep; 201():112461. PubMed ID: 32663641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]